HIV-associated nephropathy: Experimental models

Contributions to Nephrology

Volumn 169, Issue , 2011, Pages 270-285

  Avila Casado, Carmen ^a   Fortoul, Teresa I ^b   Chugh, Sumant S ^c  

^a INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL; ARTICLE; DISEASE MODEL; FOCAL GLOMERULOSCLEROSIS; GLOMERULUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ISOLATION AND PURIFICATION; MOUSE; PATHOLOGY; PODOCYTE; RAT; TRANSGENIC MOUSE; VIROLOGY;

AIDS-ASSOCIATED NEPHROPATHY; ANIMALS; DISEASE MODELS, ANIMAL; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HIV INFECTIONS; HIV-1; HUMANS; KIDNEY GLOMERULUS; MICE; MICE, TRANSGENIC; PODOCYTES; RATS;

EID: 79551477339     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000320212     Document Type: Article

References (53)

1. World Health Organization: Global Summary of the HIV/AIDS Statistics. UNAIDS Progress Report 2009 (Epiupdate). Geneva, WHO, 2009.
2. DAgati V, Appel GB: HIV infection and the kidney. J Am Soc Nephrol 2005;16:2403-2411.
3. Gardenswartz MH, Lerner CW, Seligson OR, Zabetakis PM, Rotterdam H, Tapper ML, Michelis MF, Bruno MS: Renal disease in patients with AIDS: a clinicopathologic study. Clin Nephrol 1984;21:197-204.
4. Soriano Rosas J, Avila- Casado MC, Carrera- González E, Chavez- Mercado L, Cruz Ortiz H, Rojo J: AIDS-associated nephropathy: 5- year retrospective morphologic analysis of 87 cases. Pathol Res Pract 1998;194:567-570.
5. Barisoni L, Bruggeman LA, Mundel P, DAgati VD, Klotman PE: HIV- 1 induces renal epithelial dedifferentiation in a transgenic model of HIVassociated nephropathy. Kidney Int 2000;58:173-181.
6. Barisoni L, Kriz W, Mundel P, DAgati V: The dysregulated podocyte phenotype: a novel concept in the pathogenesis of collapsing idiopathic focal segmental glomerulosclerosis and HIV- associated nephropathy. J Am Soc Nephrol 1999;10:51-61.
7. Dickie P, Felser J, Eckhaus M, Bryant J, Silver J, Marinos N, Notkins AL: HIV- associated nephropathy in transgenic mice expressing HIV- 1 genes. Virology 1991;185:109-119.
8. DAgati V, Suh JI, Carbone L, Cheng IT, Appel G: The pathology of HIV nephropathy: a detailed morphologic and comparative study. Kidney Int 1989;35:1358-1370.
9. Itescu S, Brancato LI, Buxbaum I, Oregersen PK, Rizk CC, Croxson S, Solomon O, Winchester R: A diffuse infiltrative CD8 lymphocytosis syndrome in human (HIV) infection: a host immune response associated with HLADR5 Ann Intern Med 1990;12:3-10.
10. Itescu S, Brancato LI, Winchester R: A sicca syndrome in HIV infection: association with HLA- DR5 and CD8 lymphocytosis. Lancet 1989;2:466-468.
11. Itescu S, Rose 5, Dwyer E, Winchester R: Certain HLA- DR5 and - DR6 major histocompatibility complex class II alleles are associated with a CD8 lymphocytic host response to human immunodeficiency virus type I characterized by low lymphocyte viral strain heterogeneity and slow disease progression. Proc Natl Acad Sci USA 1994;91:11472-11476.
12. Bruggeman LA, Dikman S, Meng C, Quaggin SE, Coffman TM, Klotman PE: Nephropathy in human immunodeficiency virus- 1 transgenic mice is due to renal transgene expression. J Clin Invest 1997;100:84-92.
13. Conaldi PG, Biancone L, Bottelli A, Wade- Evans A, Racusen LC, Boccellino M, Orlandi V, Serra C, Camussi G, Toniolo A: HIV- 1 kills renal tubular epithelial cells in vitro by triggering an apoptotic pathway involving caspase activation and Fas upregulation. J Clin Invest 1998;102:2041-2049.
14. Albert I, Olausson E, AsJo B: Distinct replicative and cytopathic characteristics of human immunodeficiency virus isolates. J Virol 1988;62:4414-4419.
15. Cboyd NW, Moore BE: Spectrum of biological properties of human immunodeficiency virus (HIV- l) isolates. J Virol 1990;174:103-106.
16. Zhu T, Mo H, Wang N, Nam DS, Cao Y, Koup RA, Ho DD: Oenotypic and phenotypic characterization of HIV- 1 patients with primary infection. Science 1993;261:1179-1181.
17. Karlsson- Parra A, Dimeney E, Fellstrom B, Klarkeskog L: HIV receptors (CD4 antigen) in normal human glomerular cells. N Engl J Med 1989;320:741-747.
18. Green DF, Resnick L, Bourgoignie JJ: HIV infects glomerular endothelial and mesangial but not epithelial cells in vitro. Kidney Int 1992;4l:956-960.
19. Alpers CE, McClure I, Bursten SL: Human mesangial cells are resistant to productive infection by multiple strains of human immunodeficiency virus types 1 and 2. Am J Kidney Dis 1992;19:126-130.
20. Nadasdy T, Hanson- Painton O, Davis LD, Miller KW, DeBault L, Burns D, Silva FG: Conditions affecting the immunohistochemical detection of HIV in fixed and embedded renal and nonrenal tissues. Mod Pathol 1992; 5:283-291.
21. Pardo V, Shapshak P, Yoshioka M, et al: HIV- associated nephropathy (HIVN): Direct viral invasion or indirect glomerular involvement (abstract). FASEB J 1991;5:907A.
22. Striker GE, Mannik M, Tung MY: Role of marrow- derived monocytes and mesangial cells in removal of immune complexes from renal glomeruli. J Exp Med 1979;149:127-136
23. Nagata M, Kriz W: Glomerular damage after uninephrectomy in young rats. II. Mechanical stress of podocytes as a pathway to sclerosis. Kidney Int 1992;42:148-160.
24. Clapham PR, Weber in, Whitby D, Mcintosh K, Daloleish AG, Maddon PT, Deen KC, SwetRW, Weiss RA: Soluble CD4 blocks the infectivity of diverse strains of HIV and SlY for T cells and monocytes but not for brain and muscle cells. Nature 1989;337:368-370.
25. Mckeating JA, Griffiths PD, Weiss RA: HIV susceptibility conferred to human fibroblasts by cytomegalovirus- induced Fe receptor. Nature 1990;343:659-661.
26. Raffanti S, Svennigsson A, Resnick L: HIV- l infection of CD4 negative cells via HTLV pseudoviruses. AIDS 1991;5:769-772.
27. Kajiyama W, Kopp JB, Marinos NJ, Klotman PE, Dickie P: Glomerulosclerosis and viral gene expression in HIV- transgenic mice. Kidney Int 2000;58:1148-1159.
28. Bruggeman LA, Dikman S, Meng Ch, Quaggin SE, Coffman TM, Klotman PE: Nephropathy in human immunodeficiency virus- 1 transgenic mice is due to renal transgene expression. J Clinical Invest 1997;100:84-92.
29. Dantal J, Bigot E, Bogers W, et al: Effect of plasma protein adsorption on protein excretion in kidneytransplant recipient with recurrent nephrotic syndrome. N Engl J Med 1994;30:7-14.
30. Cheung PK, Klok PA, Bakker WW: Minimal change- like alterations induced by a human plasma factor. Nephron 1996;74:586-593.
31. Marras D, Bruggeman LA, Gao F, et al: Replication and compartmentalization of HIV- 1 in kidney epithelium of patients with HIV- associated nephropathy. Nat Med 2002;8:522-524.
32. Ray PE, Liu XH, Henry D, Dye L, Xu L, Orenstein JM, Schutzbank TE: Infection of human primary renal epithelial cells with HIV- 1 from children with HIV- associated nephropathy. Kidney Int 1998:53;1217-1229
33. Kopp JB, Klotman ME, Adler SH, Bruggeman LA, Dickie P, Marinos NJ, Eckhaus M, Bryant JL, Notkins AL, Klotman PE: Progressive glomerulosclerosis and enhanced renal accumulation of basement membrane components in mice transgenic for HIV- 1 genes. Proc Natl Acad Sci USA 1992;89:1577-1582.
34. Kemeny E, Durmuller U, Nickeleit V, Gudat F, Mihatsch MJ: Distribution of podocyte protein (44 kD) in different types of glomerular diseases. Virchows Arch 1997;431:425-430.
35. Kreidberg JA, Sariola H, Loring JM, Maeda M, Pelletier J, Housman D, Jaenisch R: WT- 1 is required for early kidney development. Cell 1993;74:679-691.
36. Thomas PE, Wharram BL, Goyal M, Wiggins JE, Holzman LB, Wiggins RC: GLEPP- 1, a renal glomerular epithelial (podocyte) membrane protein tyrosine phosphatase: identification, molecular cloning, and characterization in rabbit. J Biol Chem 1994;269: 19953-19962.
37. Mundel P, Gilbert P, Kriz W: Podocytes in glomerulus of rat kidney express a characteristic 44 kD protein. J Histochem Cytochem 1991:39:1047-1056.
38. DAgati V: The many masks of focal segmental glomerulosclerosis. Kidney Int 1994;46:1223-1241.
39. Rennke HG: How does glomerular epithelial cell injury contribute to progressive glomerular damage? Kidney Int 1994;45:S58-S63.
40. Kriz W: Progressive renal failureinability of podocytes to replicate and the consequences for development of glomerulosclerosis. Nephrol Dial Transplant 1996;11:1738-1742.
41. Kriz W, Gretz N, Lemley KV: Progression of glomerular diseases: is the podocyte the culprit? Kidney Int 1998;54:687-697.
42. Sharif K, Goyal M, Kershaw D, Kunkel R, Wiggins R: Podocyte phenotypes as defined by expression and distribution of GLEPP- 1 in the developing glomerulus and in nephritic glomeruli from MCD, CNF, and FSGS: a dedifferentiation hypothesis for the nephrotic syndrome. Exp Nephrol 1998;6:234-244.
43. Kriz W, Hähnel B, Rösener S, Elger M: Long- term treatment of rats with FGF- 2 results in focal segmental glomerulosclerosis. Kidney Int 1995;48:1435-1450.
44. Shankland SJ: Cell- cycle control and renal disease. Kidney Int 1997;52:294-308.
45. Kitamoto Y, Tokunaga H, Tomita K: Vascular endothelial growth factor is an essential molecule for mouse kidney development: glomerulogenesis and nephrogenesis. J Clin Invest 1997;99:2351-2357.
46. Weiss MA, Daquioag E, Margolin EG, Pollak VE: Nephrotic syndrome, progressive irreversible renal failure, and glomerular collapse: a new clinicopathologic entity? Am J Kidney Dis 1986;7:20-28.
47. Avila- Casado C, Galvanek EG, Rennke HG: Collapsing Glomerulopathy (CG) developing in the renal allograft (abstract). J Am Soc Nephrol 1994;5:994.
48. Stokes MB, Davis CL, Alpers CE: Collapsing glomerulopathy in renal allografts: a morphological pattern with diverse clinicopathological associations. Am J Kidney Dis 1999;33:658-666.
49. Avila- Casado MC, Perez- Torres I, Auron A, Soto V, Fortoul TI, Herrera- Acosta J: Proteinuria in rats induced by serum from patients with collapsing glomerulopathy. Kidney Int 2004;66:133-143.
50. Artero ML, Sharma R, Savin VI, et al: plasmapheresis reduces proteinuria and serum capacity to injure glomeruli in patients with recurrent focal glomerulosclerosis. Am J Kidney Dis 1994;23:574-581.
51. Gornall AG, Bardawill CJ, Davis M: Determination of serum proteins by means of Biuret reaction. J Biol Chem 1949;177:751-766.
52. Smith SR, Suetkey LP, Dennis VA: Racial differences in the incidence and progression of renal diseases. Kidney Int 1991;40:815-822.
53. Avila- Casado C, Perez- Torres I, Bochicchio T, Torres- Rosales A, Lopez E, Niño JA, For toul TI: Clinical characteristics and outcomes in FSGS patients with circulating factors (abstract). J Am Soc Nephrol 2007;18:565A.